Strumento inattivo

Azioni MAP Pharmaceuticals Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	26/01/13
MAP Pharmaceuticals Inc. : Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : INVESTOR ALERT: Brannon Law Firm, L.L.C. is Investigating the Proposed Tender Offer/Merger of MAP Pharmaceuticals, Inc. by Allergan, Inc.	23/01/13
MAP Pharmaceuticals Inc. : Law Firm Brower Piven Announces Investigation of MAP Pharmaceuticals, Inc.	23/01/13

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+7,52%	113 Mrd
REGENERON PHARMACEUTICALS, INC.	+11,38%	106 Mrd
ARGENX SE	+0,49%	22,27 Mrd
BIONTECH SE	-12,64%	22,22 Mrd
GENMAB A/S	-4,22%	19,43 Mrd
WUXI APPTEC CO., LTD.	-37,85%	17,87 Mrd
BEIGENE, LTD.	-8,58%	17,24 Mrd
NEUROCRINE BIOSCIENCES, INC.	+7,77%	14,29 Mrd
SAREPTA THERAPEUTICS, INC.	+37,41%	12,52 Mrd